Skip to NavigationSkip to content

AstraZeneca spends more than twice as much as expected on new HQ

Published on 12/06/19 at 03:10pm
Image Credit: AstraZeneca

AstraZeneca’s new headquarters in Cambridge, United Kingdom are expected to cost more than double the sum of £330 million that the firm budgeted for in 2013.

At a cost of £750 million so far, AstraZeneca’s new donut-shaped HQ is set to become one of the most expensive corporate buildings in the UK.  

According to AstraZeneca, the construction costs associated with the building of the 580,000 metres square headquarters on a biomedical campus south of Cambridge have soared due to “increased investment in new technologies and equipment.”

While AstraZeneca had originally hoped to move in by 2016, the Anglo-Swedish multinational now hopes to make its move into its new headquarters next year.

The building of the new HQ comes after AstraZeneca CEO Pascal Soriot decided to move the company London after he took over the firm in 2012.

AstraZeneca’s big investment in its new Cambridge headquarters has been seen as evidence of the firm’s commitment to Britain as a biopharma hub.

AstraZeneca’s new building will come in shortly behind Bloomberg’s £1 billion Foster + Partners-designed HQ in London as one of the most expensive corporate buildings in Britain.

For comparison, GlaxoSmithKline’s Brentford HQ cost the UK firm £350 million in 2002, while the Royal Bank of Scotland’s Edinburgh head office cost £350 million in 2005.

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches